The Board of Directors of Pasithea Therapeutics Corp. has authorized a buyback plan on August 9, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.05 USD | -0.84% | +1.88% | -4.73% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.73% | 7.35M | |
+2.60% | 108B | |
+9.21% | 105B | |
+1.11% | 23.46B | |
-14.50% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-7.60% | 17.19B | |
+5.50% | 13.99B | |
+36.95% | 12.53B |
- Stock Market
- Equities
- KTTA Stock
- News Pasithea Therapeutics Corp.
- Pasithea Therapeutics Corp. authorizes a Buyback Plan.